Search research articles
Contact Us
Filters
Showing results (11-20 of 141) with videos related to
Page
of 15
Sort By:
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics
|
September 27, 2017
Remyelinating Pharmacotherapies in Multiple Sclerosis
Riley M Bove, Ari J Green
Brain : a Journal of Neurology
|
May 8, 2013
Reply: Microcystic macular degeneration from optic neuropathy: not inflammatory, not trans-synaptic degeneration
Jeffrey M Gelfand, Ari J Green
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
December 5, 2025
Remyelination therapies are achievable in clinical practice-Yes
Leah Zuroff, Christian Cordano, Ari J Green
Neurology
|
April 21, 2019
Personalizing medical care for patients with MS: Monitoring brainstem damage by infrared oculography
Pablo Villoslada, Ari J Green, Steven Galetta
JAMA Neurology
|
April 3, 2023
Challenges and Opportunities for the Promising Biomarker Blood Neurofilament Light Chain
Ahmed Abdelhak, Jens Kuhle, Ari J Green
Neurorx : the Journal of the American Society for Experimental Neurotherapeutics
|
March 24, 2006
Pediatric multiple sclerosis
Dorothée Chabas, Ari J Green, Emmanuelle Waubant
Brain : a Journal of Neurology
|
July 23, 2013
Reply: Microcysts in the inner nuclear layer from optic atrophy are caused by retrograde trans-synaptic degeneration combined with vitreous traction on the retinal surface
Ari J Green, Daniel Schwartz, Jeffrey Gelfand
Neurology
|
December 11, 2012
Fingolimod treatment in multiple sclerosis leads to increased macular volume
Rachel Nolan, Jeffrey M Gelfand, Ari J Green
JAMA Neurology
|
November 19, 2017
Combating the Spread of Ineffective Medical Procedures: A Lesson Learned From Multiple Sclerosis
Ari J Green, Hooman Kamel, S Andrew Josephson
JAMA Neurology
|
April 11, 2020
The Spectrum of Neurologic Disease in the Severe Acute Respiratory Syndrome Coronavirus 2 Pandemic Infection: Neurologists Move to the Frontlines
Samuel J Pleasure, Ari J Green, S Andrew Josephson
Page
of 15
Search research articles
Search
Showing results (11-20 of 141) with videos related to
Sort By:
Page
of 15
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics
|
September 27, 2017
Remyelinating Pharmacotherapies in Multiple Sclerosis
Riley M Bove, Ari J Green
Brain : a Journal of Neurology
|
May 8, 2013
Reply: Microcystic macular degeneration from optic neuropathy: not inflammatory, not trans-synaptic degeneration
Jeffrey M Gelfand, Ari J Green
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
December 5, 2025
Remyelination therapies are achievable in clinical practice-Yes
Leah Zuroff, Christian Cordano, Ari J Green
Neurology
|
April 21, 2019
Personalizing medical care for patients with MS: Monitoring brainstem damage by infrared oculography
Pablo Villoslada, Ari J Green, Steven Galetta
JAMA Neurology
|
April 3, 2023
Challenges and Opportunities for the Promising Biomarker Blood Neurofilament Light Chain
Ahmed Abdelhak, Jens Kuhle, Ari J Green
Neurorx : the Journal of the American Society for Experimental Neurotherapeutics
|
March 24, 2006
Pediatric multiple sclerosis
Dorothée Chabas, Ari J Green, Emmanuelle Waubant
Brain : a Journal of Neurology
|
July 23, 2013
Reply: Microcysts in the inner nuclear layer from optic atrophy are caused by retrograde trans-synaptic degeneration combined with vitreous traction on the retinal surface
Ari J Green, Daniel Schwartz, Jeffrey Gelfand
Neurology
|
December 11, 2012
Fingolimod treatment in multiple sclerosis leads to increased macular volume
Rachel Nolan, Jeffrey M Gelfand, Ari J Green
JAMA Neurology
|
November 19, 2017
Combating the Spread of Ineffective Medical Procedures: A Lesson Learned From Multiple Sclerosis
Ari J Green, Hooman Kamel, S Andrew Josephson
JAMA Neurology
|
April 11, 2020
The Spectrum of Neurologic Disease in the Severe Acute Respiratory Syndrome Coronavirus 2 Pandemic Infection: Neurologists Move to the Frontlines
Samuel J Pleasure, Ari J Green, S Andrew Josephson
Page
of 15